Weehuizen, Tassili A F <br/><br/>
Therapeutic Administration of a Monoclonal Anti-Il-1β Antibody Protects Against Experimental Melioidosis.  [electronic resource] 

 -  Shock (Augusta, Ga.)  11 2016 
 - 566-574 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1540-0514 
<br/><br/><label>Standard No.: </label>10.1097/SHK.0000000000000625  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Burkholderia pseudomallei--pathogenicity<br/>Disease Models, Animal<br/>Humans<br/>Inflammasomes--drug effects<br/>Interleukin-1beta--antagonists & inhibitors<br/>Melioidosis--drug therapy<br/>Middle Aged<br/>NLR Family, Pyrin Domain-Containing 3 Protein--genetics<br/>RNA, Messenger--genetics<br/>Young Adult